about
Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy.Fifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.Host adaptive immunity deficiency in severe pandemic influenza.Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenzaIdentification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy.Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study.Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.Relationship between European mitochondrial haplogroups and chronic renal allograft rejection in patients with kidney transplant.Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study.FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional studyrs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factorsRelationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysisAssociation between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional studyEarly natural killer cell counts in blood predict mortality in severe sepsis.Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of OutcomeImpact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in SpainEnvironmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012).Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patientsMx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study.IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study.Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis.Trends in nontuberculous mycobacterial disease in hospitalized subjects in Spain (1997-2010) according to HIV infection.Incidence and mortality of tuberculosis disease in Spain between 1997 and 2010: impact of human immunodeficiency virus (HIV) status.Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008).Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
P50
Q25257691-BFA0C5EE-DC52-41CB-9854-81419C08981FQ28553878-D2DABC5A-E7DF-4FB2-9CC9-FC93BD4DEF76Q30386775-F8798845-3ACD-4E5A-BD1E-656C1FD10801Q30393612-BAB16C47-0DAA-4504-B248-4B6A9014672FQ30406559-D054AD2F-3DDC-4FA8-9EE6-A05714BD04EAQ31139499-FAC253D3-EBF3-426A-B883-7C4A7F24CB6AQ33249816-EC6925EA-3790-497C-A186-5472027603E1Q33250098-0EC92459-74E7-4B54-8C72-E6029A77B724Q33321334-943C1EB9-098A-4773-A5B0-66EE6F9966D6Q33387711-5E672E98-B10E-4B89-97D8-00CB5C899049Q33665359-293E8732-CC8A-4A10-A656-2E983A64028EQ33767618-A310BF39-392D-46E0-84A1-589F42A8F92BQ33803319-C9E5EABD-7056-421F-B5FB-AE4B350A5C06Q34102044-59D5EBBA-2D96-4246-8F02-AEA37642503EQ34250648-AD7D464E-2A12-4A04-AA3E-0AC7D1DD62DFQ34346288-1CC98979-362B-4A8B-98C9-47E697498D3EQ34474404-90FFB01F-1668-42CC-8B12-69A2169065C6Q34481988-7AEEB0D8-6FD1-4D43-900D-126E1C1EA035Q34539324-9ADAA9E2-303E-4849-93BC-00DB643F0D43Q34627658-16B98EBE-A574-4828-AF5D-5C8891D36AC3Q34803775-E1EC4B0C-CC99-4612-93E2-68B814705CE5Q35142495-43910A21-7752-40D6-933E-7D34892B17DDQ35197174-C7D741CB-0796-4E3B-BE37-E38E7FA1599FQ35634844-BC1870B0-C731-4D99-8759-61318747AF98Q35799774-18C22F65-3AFD-4F68-9096-2BFDA22D5E7CQ35803583-F943D127-0B91-46DE-A85D-61F2D330DC5DQ35908269-0AC09673-15D9-49FF-8564-3C547CDA66E7Q35916020-9F6E4B1D-BC87-40D1-B52C-3761158D95ECQ35958590-7421C20D-4888-49E8-8441-58255C4E23B4Q36148440-92A41E6B-22D0-4A4E-9212-83A2E284FBC8Q36182343-DC81805C-D649-43DF-AE6F-456A1B62EB52Q36192956-5BBD74DB-1B08-4973-99D3-355576E1BA8CQ37230823-4FF4B62E-E378-41D9-A60B-1B1683F285FBQ37615221-7017BEC5-63E4-48B9-8C04-0D9BCD504D50Q37672359-1FEE725C-6A11-4D86-A414-02B3D88B289AQ38022504-ADF435C7-0019-4B01-8A12-D83154BBBA2BQ38415403-335DD288-A7C5-4087-A9E8-C90E5503BEB6Q38423031-3380A3AC-6714-4124-BF36-5D35C0D1EB40Q38436381-FA0598F0-C3DA-49CF-B6FD-590DAC8180CCQ38439224-1B92B62F-758F-411D-AA84-932A7BC33B5A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvador Resino
@ast
Salvador Resino
@en
Salvador Resino
@es
Salvador Resino
@sl
type
label
Salvador Resino
@ast
Salvador Resino
@en
Salvador Resino
@es
Salvador Resino
@sl
prefLabel
Salvador Resino
@ast
Salvador Resino
@en
Salvador Resino
@es
Salvador Resino
@sl
P108
P106
P21
P31
P3835
salvador-resino
P496
0000-0001-8783-0450